US FDA rescinds 510(k) clearance of ReGen's Menaflex
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has officially retracted its pre-market notification (510(k)) clearance of ReGen Biologics' Menaflex meniscus implant, forcing the firm to remove it from sale in the US1.